298 results found

Implementation of alcohol health warning labels under Ireland's Public Health (Alcohol) Act 2018 has been postponed to September 2028.

Three important regulatory developments occurred during 2017 which may be of significant benefit to patients, families, practitioners and indemnifiers alike. We examine the scope of these developments and their likely impact on the provision of healthcare in Ireland

The ECJ’s recent decision in Commission v Ireland (Case C-82/10) is likely to have significant effect on the private health insurance market in Ireland.

The Supreme Court in Delaney v The Personal Injuries Board & Ors, has confirmed the validity and continued operation of Personal Injury Guidelines (Guidelines)...

The MSR, which comes into force on 16 July 2021, aims to "complement and strengthen" existing EU product legislation.

CORU is responsible for regulating 12 different health and social care professions, and has the responsibility for promoting high standards of professional conduct and education.

On 27 May 2015 Minister for Justice and Equality, Frances Fitzgerald TD, published the long awaited general scheme of the Civil Liability (Amendment) Bill 2015.

We talk to Oliver O'Connor, CEO, Irish Pharmaceutical Healthcare Association, about his role, his career journey and his views on some key issues faced by the industry.

The Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (the "Act") was commenced last month on 26 September 2024 by the Minister for Health.

In considering whether to grant discovery of statements made by hospital staff to a risk management enquiry, the High Court had to consider two competing public interests, namely the public...

As of this morning, 30 January 2020, the World Health Organisation ("WHO") has assessed the global risk for the Coronavirus as a "high risk".

Three important regulatory developments occurred during 2017 which may be of significant benefit to patients, families, practitioners and indemnifiers alike.

On Thursday, 5 November 2015, the Court of Appeal delivered its much anticipated Judgment in the case of Gill Russell v HSE in relation to the "real rate of return".

A discussion on the recently introduced EU Falsified Medicines Directive.

A significant development on the pan-European life sciences front, was the July publication by the European Commission (the "Commission") of its long-awaited Life Sciences Strategy.

The Court of Appeal (CoA) has dismissed an appeal brought by a consultant oncologist (appellant) in respect of a finding against him of poor professional performance (Finding) ...

Medical practitioners often find themselves in the unenviable position of having to decide whether to withdraw or discontinue treatment that is artificially prolonging a patient's life.